## Purpose: To evaluate reproducibility of total cerebral blood flow (cbf) measurements with phase contrast magnetic resonance imaging (pcmri). ## Materials and methods: We repeated total cbf measurements in 15 healthy volunteers with and without cardiac triggering, and with and without repositio
Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography
β Scribed by David Bonekamp; Mahaveer Degaonkar; Peter B. Barker
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 492 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Dynamic susceptibility contrast magnetic resonance imaging during bolus injection of gadolinium contrast agent is commonly used to investigate cerebral hemodynamics. The large majority of clinical applications of dynamic susceptibility contrast magnetic resonance imaging to date have reported relative cerebral blood flow values because of dependence of the result on the accuracy of determining the arterial input function, the robustness of the singular value decomposition algorithm, and others. We propose a calibration approach that directly measures the total (i.e., whole brain) cerebral blood flow in individual subjects using phase contrast magnetic resonance angiography. The method was applied to data from 11 patients with intracranial pathology. The sum of squares variance about the mean (uncorrected: white matter = 105.6, gray matter = 472.2; corrected: white matter = 34.1, gray matter = 99.8) after correction was significantly lower for white matter (P = 0.045) and for gray matter (P = 0.011). However, the mean gray and white matter cerebral blood flow in the contralateral hemisphere were not significantly altered by the correction. The proposed phase contrast magnetic resonance angiography calibration technique appears to be one of the most direct correction schemes available for dynamic susceptibility contrast magnetic resonance imaging cerebral blood flow values and can be performed rapidly, requiring only a few minutes of additional scan time. Magn Reson Med, 2011. Β© 2011 WileyβLiss, Inc.
π SIMILAR VOLUMES
For quantification of cerebral blood flow (CBF) using dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI), knowledge of the tissue response function is necessary. To obtain this, the tissue contrast passage measurement must be corrected for the arterial input. This study proposes an
## Abstract In dynamicβsusceptibility contrast magnetic resonance perfusion imaging, the cerebral blood flow (CBF) is estimated from the tissue residue function obtained through deconvolution of the contrast concentration functions. However, the reliability of CBF estimates obtained by deconvolutio
## Abstract ## Purpose To compare absolute cerebral blood flow (CBF) estimates obtained by dynamic susceptibility contrast MRI (DSCβMRI) and Xeβ133 SPECT. ## Materials and Methods CBF was measured in 20 healthy volunteers using DSCβMRI at 3T and Xeβ133 SPECT. DSCβMRI was accomplished by gradient
## Abstract Pharmacological MRI (phMRI) techniques can be used to monitor the neurophysiological effects of central nervous system (CNS) active drugs. In this study, we investigated whether dynamic susceptibility contrast (DSC) perfusion imaging employing the use of superparamagnetic iron oxide nan